Related Experiment Video
Updated: Jun 10, 2026
11:29
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Pathophysiological roles for purines: adenosine, caffeine and urate
Micaela Morelli1, Anna R Carta, Anil Kachroo
1Department of Toxicology, University of Cagliari, Cagliari, Italy. morelli@unica.it
Progress in Brain Research
|August 11, 2010
Summary
Parkinson's disease involves more than just dopamine. Adenosine A(2A) receptor antagonists show promise for treating Parkinson's symptoms and potentially protecting brain cells.
Area of Science:
- Neuroscience
- Pharmacology
- Neurology
Background:
- Parkinson's disease (PD) motor symptoms stem from dopaminergic neuron loss.
- Non-dopaminergic systems (noradrenaline, serotonin, acetylcholine) and adenosine are implicated in PD.
- Dopamine-based treatments have limitations and side effects, necessitating broader therapeutic strategies.
Purpose of the Study:
- To review the rationale for adenosine A(2A) receptor antagonists in PD.
- To explore interactions between dopamine and adenosine receptors in PD treatment.
- To highlight urate as a potential biomarker and neuroprotectant for PD.
Main Methods:
- Literature review of pre-clinical and clinical studies.
- Analysis of adenosine A(2A) receptor-receptor interactions.
- Examination of urate's role in purine metabolism and PD.
Main Results:
- Adenosine A(2A) receptor antagonists offer symptomatic and potential neuroprotective benefits for PD.
- Specific receptor interactions provide a basis for A(2A) antagonist development.
- Urate emerges as a novel prognostic biomarker and potential neuroprotective agent in PD.
Conclusions:
- Targeting adenosine A(2A) receptors represents a promising therapeutic avenue beyond conventional dopaminergic drugs for Parkinson's disease.
- Urate's dual role as a biomarker and neuroprotectant warrants further investigation in PD management.
Related Concept Videos
01:28Biosynthesis of Nucleic Acids
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:18Adrenergic Agonists: Therapeutic Classification
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
01:30Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...